Cns Pharmaceuticals Inc (CNSP) concluded trading on Tuesday at a closing price of $0.12, with 13.28 million shares of worth about $1.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -90.44% during that period and on December 31, 2024 the price saw a gain of about 6.55%. Currently the company’s common shares owned by public are about 57.49M shares, out of which, 56.89M shares are available for trading.
Stock saw a price change of 10.46% in past 5 days and over the past one month there was a price change of 7.50%. Year-to-date (YTD), CNSP shares are showing a performance of -99.81% which decreased to -99.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.10 but also hit the highest price of $65.00 during that period. The average intraday trading volume for Cns Pharmaceuticals Inc shares is 16.19 million. The stock is currently trading 10.76% above its 20-day simple moving average (SMA20), while that difference is up 2.36% for SMA50 and it goes to -96.84% lower than SMA200.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) currently have 57.49M outstanding shares and institutions hold larger chunk of about 2.85% of that.
The stock has a current market capitalization of $7.37M and its 3Y-monthly beta is at 1.03. It has posted earnings per share of -$75.02 in the same period. It has Quick Ratio of 1.81 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CNSP, volatility over the week remained 11.56% while standing at 11.70% over the month.
Coverage by Ladenburg Thalmann stated Cns Pharmaceuticals Inc (CNSP) stock as a Buy in their note to investors on August 24, 2020, suggesting a price target of $11 for the stock.
